Genentech on The Opinions

The OpinionsJuly 29, 2026

Is More Data About Your Body Actually Good for You?

0:35
pre-roll
The New York Times Opinion
The New York Times Opinion
July 29, 2026
Host-read (by The New York Times Opinion)Brand awarenessBaked-in adHealthcare
0:00 / 0:35
@ in ep

Transcript

As the original biotech company, Genentech has spent the last 50 years pushing scientific boundaries and redefining what's possible by continuously challenging the status quo. They've been at the forefront of more than 40 breakthroughs across various diseases, including multiple sclerosis, cancer, vision loss, and food allergies. And these breakthroughs in the lab allow for greater breakthroughs in patients' lives, whether it's getting back to familiar routines or creating new ones. Learn more about Genentech's lasting impact at gene.com. That's G-E-N-E dot com.

Auto-transcribed · verbatim audio matches · Report an error

Estimated ad cost

~$300range $49$2,000

Estimate of what a similar one-episode podcast ad would cost based on rank, placement, and duration

Methodology and limitations →

Genentech sponsor landing page on The Opinions

Genentech sponsor landing page advertised on The Opinions

Genentech landing page captured for its sponsorship on The Opinions.

gene.com/

Episode

The Opinions
Is More Data About Your Body Actually Good for You?
Host: The New York Times Opinion
Publisher: The New York Times Opinion